Schedule 13D ownership disclosure

Black Diamond Therapeutics Inc

Security class unavailable · CUSIP: 09203E105

Event date: 2024-05-09

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
7.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001072613-24-000469
Form type
SC 13D/A
Filer
Black Diamond Therapeutics, Inc.
CIK
CIK 1701541
Filed
May 13, 2024
Reporting period
May 09, 2024
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub